KBC Group
AGN

KBC Group’s Allergan plc AGN Stock Holding History

KBC Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-453,240
Closed -$80.3M – 1344
2020
Q1 		$80.3M Buy
453,240
+214,631
+90% +$40.4M 0.67% 27
2019
Q4 		$45.6M Sell
238,609
-20,601
-8% -$3.72M 0.29% 77
2019
Q3 		$43.6M Buy
259,210
+37,585
+17% +$6.12M 0.32% 61
2019
Q2 		$37.1M Buy
221,625
+4,450
+2% +$616K 0.29% 78
2019
Q1 		$31.8M Sell
217,175
-67,533
-24% -$9.79M 0.26% 85
2018
Q4 		$38.1M Sell
284,708
-18,397
-6% -$3.02M 0.42% 55
2018
Q3 		$57.7M Buy
303,105
+52,911
+21% +$9.72M 0.44% 46
2018
Q2 		$41.7M Sell
250,194
-30,832
-11% -$4.95M 0.36% 59
2018
Q1 		$47.3M Sell
281,026
-51,460
-15% -$8.63M 0.44% 48
2017
Q4 		$54.4M Buy
332,486
+31,705
+11% +$5.69M 0.46% 43
2017
Q3 		$61.6M Sell
300,781
-10,125
-3% -$2.35M 0.56% 33
2017
Q2 		$75.6M Buy
310,906
+4,590
+1% +$1.08M 0.73% 19
2017
Q1 		$73.2M Buy
306,316
+35,000
+13% +$8.15M 0.66% 20
2016
Q4 		$57M Buy
271,316
+72,103
+36% +$14.9M 0.56% 30
2016
Q3 		$45.9M Buy
199,213
+62,529
+46% +$15.3M 0.54% 39
2016
Q2 		$31.6M Buy
136,684
+28,442
+26% +$6.56M 0.45% 47
2016
Q1 		$29M Buy
108,242
+12,291
+13% +$3.52M 0.48% 40
2015
Q4 		$30M Sell
95,951
-540
-0.6% -$161K 0.55% 31
2015
Q3 		$26.2M Sell
96,491
-17,215
-15% -$5.29M 0.53% 31
2015
Q2 		$34.5M Sell
113,706
-22,544
-17% -$6.72M 0.44% 46
2015
Q1 		$40.6M Buy
136,250
+58,719
+76% +$16.7M 0.52% 34
2014
Q4 		$20M Buy
77,531
+66,315
+591% +$16.6M 0.24% 94
2014
Q3 		$2.71M Sell
11,216
-85,509
-88% -$19.1M 0.09% 281
2014
Q2 		$21.6M Buy
96,725
+4,672
+5% +$967K 0.25% 85
2014
Q1 		$18.9M Sell
92,053
-95,197
-51% -$18.9M 0.3% 70
2013
Q4 		$31.5M Buy
187,250
+36,355
+24% +$5.68M 0.48% 44
2013
Q3 		$21.7M Buy
150,895
+9,445
+7% +$1.26M 0.35% 64
2013
Q2 		$17.9M Buy
+141,450
New +$16M 0.33% 69

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

KBC Group's AGN Position: Q2 2020 in Review

KBC Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 453,240 shares — an estimated $80.3M sold.

KBC Group first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $80.3M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • KBC Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • KBC Group sold 453,240 Allergan plc shares in Q2 2020, an estimated $80.3M.
  • KBC Group first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • KBC Group's Allergan plc position peaked at $80.3M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on KBC Group's 13F filing for Q2 2020, filed 10 Aug 2020.